Zcash Price Eyes $500 Breakout as ZEC Holds Key Support
3 Articles
3 Articles
Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Winklevoss-backed Zcash (ZEC) treasury company Cypherpunk Technologies has announced plans to pivot focus to its cancer drug candidate after it reported a $37.8 million net loss for the first six months of 2026. Unless the price of ZEC rallies soon, the company has admitted that it will need to raise a lot of money to pay for its upcoming FDA trials. “We expect to continue to generate operating losses for the foreseeable future,” the company for…
Zcash Price Eyes $500 Breakout as ZEC Holds Key Support
Zcash (ZEC) remains technically bullish despite another rejection above the $500 level. Trading near $488, ZEC is consolidating between key short-term moving averages while preserving the broader recovery structure established after its March lows. The immediate battle for the Zcash price is concentrated between $483 and $500. ZEC remains above its 50-day moving average near $483 and the 100-day moving average around $469. However, a shorter-ter…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium






